Literature DB >> 11223540

Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis.

H Takaku1, Y Ajioka, H Watanabe, H Hashidate, S Yamada, J Yokoyama, S Kazama, T Suda, K Hatakeyama.   

Abstract

Two cases of ulcerative colitis (UC)-associated carcinoma or dysplasia and morphologically non-neoplastic mucosa with p53 protein overexpression (MNNM-p53OE) were selected. DNA was extracted from the paraffin blocks of these lesions and exons 5 - 8 of the p53 gene were analyzed by PCR and direct sequencing. In addition, mutations in K-ras codon 12 were analyzed by PCR-RFLP methods. MNNM-p53OE was located surrounding and adjoining a coexisting carcinoma and / or dysplasia. A p53 mutation was detected in 12 / 22 (54.5%) MNNM-p53OE samples, 4 / 8 (50%) dysplasia samples and 8 / 8 (100%) carcinoma samples. The p53 mutations detected in MNNM-p53OE were identical to those demonstrated in the adjoining carcinoma and / or dysplasia. No K-ras codon 12 mutation was detected in any of the samples. These results indicate that MNNM-p53OE may share an identical clonal linkage with a coexisting carcinoma and / or dysplasia, and may be an initial and submorphological form of UC-associated neoplasia. Recognition of MNNM-p53OE in biopsy specimens may help to identify patients with UC at risk of developing colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223540      PMCID: PMC5926702          DOI: 10.1111/j.1349-7006.2001.tb01073.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile.

Authors:  N Yokoyama; J Hitomi; H Watanabe; Y Ajioka; M Pruyas; I Serra; Y Shirai; K Hatakeyama
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-04       Impact factor: 4.254

3.  Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung.

Authors:  S Ohshima; Y Shimizu; M Takahama
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

Authors:  T A Brentnall; D A Crispin; P S Rabinovitch; R C Haggitt; C E Rubin; A C Stevens; G C Burmer
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

5.  Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitis.

Authors:  B Klump; K Holzmann; A Kühn; F Borchard; M Sarbia; M Gregor; R Porschen
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-08       Impact factor: 2.566

6.  Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis.

Authors:  K Holzmann; B Klump; F Borchard; C J Hsieh; A Kühn; V Gaco; M Gregor; R Porschen
Journal:  Int J Cancer       Date:  1998-03-30       Impact factor: 7.396

7.  The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.

Authors:  A E Noffsinger; M A Miller; M V Cusi; C M Fenoglio-Preiser
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

8.  p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.

Authors:  N Harpaz; A L Peck; J Yin; I Fiel; M Hontanosas; T R Tong; J N Laurin; J M Abraham; B D Greenwald; S J Meltzer
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

9.  p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein.

Authors:  W C Weinberg; C G Azzoli; K Chapman; A J Levine; S H Yuspa
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  p53 mutation in patients with ulcerative colitis in rectal biopsy.

Authors:  H J Kim; S K Chang
Journal:  Korean J Intern Med       Date:  1998-07       Impact factor: 2.884

View more
  9 in total

1.  American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells.

Authors:  Yu Jin; Anne B Hofseth; Xiangli Cui; Anthony J Windust; Deepak Poudyal; Alex A Chumanevich; Lydia E Matesic; Narendra P Singh; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

Review 2.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

3.  p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis.

Authors:  Ramanarao Dirisina; Rebecca B Katzman; Tatiana Goretsky; Elizabeth Managlia; Navdha Mittal; David B Williams; Wei Qiu; Jian Yu; Navdeep S Chandel; Lin Zhang; Terrence A Barrett
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

4.  How does inflammation drive mutagenesis in colorectal cancer?

Authors:  Chia Wei Hsu; Mark L Sowers; Willie Hsu; Eduardo Eyzaguirre; Suimin Qiu; Celia Chao; Charles P Mouton; Yuri Fofanov; Pomila Singh; Lawrence C Sowers
Journal:  Trends Cancer Res       Date:  2017

5.  Expression of p53, VEGF, microvessel density, and cyclin-D1 in noncancerous tissue of inflammatory bowel disease.

Authors:  Canan Alkim; Berna Savas; Arzu Ensari; Huseyin Alkim; Ulku Dagli; Erkan Parlak; Aysel Ulker; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2008-11-26       Impact factor: 3.199

6.  p53 mediates TNF-induced epithelial cell apoptosis in IBD.

Authors:  Tatiana Goretsky; Ramanarao Dirisina; Preetika Sinh; Navdha Mittal; Elizabeth Managlia; David B Williams; Daniela Posca; Hyunji Ryu; Rebecca B Katzman; Terrence A Barrett
Journal:  Am J Pathol       Date:  2012-08-03       Impact factor: 4.307

7.  Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.

Authors:  Haruki Sada; Manabu Shimomura; Takao Hinoi; Hiroyuki Egi; Koji Kawaguchi; Takuya Yano; Hiroaki Niitsu; Yasufumi Saitou; Hiroyuki Sawada; Masashi Miguchi; Tomohiro Adachi; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

8.  Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer.

Authors:  Paul M Nguyen; Laura F Dagley; Adele Preaudet; Philippe Bouillet; Tracy L Putoczki; Nga Lam; Maybelline Giam; Ka Yee Fung; Kaheina Aizel; Gemma van Duijneveldt; Chin Wee Tan; Yumiko Hirokawa; Hon Yan K Yip; Christopher G Love; Ashleigh R Poh; Akshay D' Cruz; Charlotte Burstroem; Rebecca Feltham; Suad M Abdirahman; Kristy Meiselbach; Ronnie Ren Jie Low; Michelle Palmieri; Matthias Ernst; Andrew I Webb; Tony Burgess; Oliver M Sieber
Journal:  Cell Death Differ       Date:  2019-07-11       Impact factor: 15.828

9.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.